Home
Novosti
Prevod
Projekat
Forum
Pomoć
Korisnici
Pristupi
Registruj se
. .
•Profil
ervintoth
•Svi prevodi
▪▪Traženi prevodi
•
Omiljeni prevodi
•Spisak projekata
•Sanduče
▪Besplatna razmena stranih jezika
•English
•Türkçe
•Français
•Español
•Italiano
•Português brasileiro
•Deutsch
•Română
•عربي
•Русский
•Svenska
•Ελληνικά
•Български
•עברית
•Shqip
▪▪Srpski
•Nederlands
•Dansk
•Português
•Polski
•汉语(简体)
•Lietuvių
•Norsk
•فارسی
•Suomi
•Hrvatski
•日本語
•Català
•Esperanto
•한국어
•Українська
•Føroyskt
•नेपाली
•Kiswahili
Svi prevodi
Traži
Traženi prevodi - ervintoth
Traži
Izvorni jezik
Željeni jezik
Rezultati 1 - 2 od oko 2
1
384
Izvorni jezik
ASSESSMENT OF SMALL BOWEL SAFETY OF LUMIRACOXIB 100 MG OD
Of 152 randomized subjects, 139 completed the study with valid VCEs. Compared with placebo, an increased number of subjects on naproxen plus omeprazole had small bowel mucosal breaks , with increased permeability and raised faecal calprotectin . .There was no increase in permeability. As assessed by three different measures, acute small bowel injury on lumiracoxib treatment is less frequent than with naproxen plus omeprazole and similar to placebo.
Završeni prevodi
Uppskattning av lumiracoxibs 100 mg od tunntarmssäkerhet
1